Literature DB >> 9837951

Essential mitotic functions of DNA topoisomerase IIalpha are not adopted by topoisomerase IIbeta in human H69 cells.

P Grue1, A Grässer, M Sehested, P B Jensen, A Uhse, T Straub, W Ness, F Boege.   

Abstract

Unique functions of mammalian DNA-topoisomerases IIalpha and -beta are suggested by their distinct cellular distribution and chromatin binding at mitosis. Here, we studied H69-VP cells that, due to a homozygous mutation, express topoisomerase IIalpha mostly outside the nucleus. In these cells topoisomerase IIbeta showed a normal nuclear localization. However, at mitosis it diffused away from the chromatin despite the nuclear lack of the alpha-isoform. 80% of these cells performed chromosome condensation and disjunction with the aid of cytosolic topoisomerase IIalpha, which bound to the mitotic chromatin with low affinity. However, the genotype of these cells was highly polyploid indicating an increased rate of non-disjunction. In 20% of the mutant cells neither topoisomerase II isoform was bound to the mitotic chromatin, which appeared as an unstructured DNA spheroid unable to undergo disjunction and cytokinesis. Parental H69 cells expressing topoisomerase IIalpha inside the nucleus exhibited high affinity binding of the enzyme to the mitotic chromatin. Their genotype was mostly diploid and stable. We conclude (i) that high affinity chromatin binding of topoisomerase IIalpha is essential for chromosome condensation/disjunction and (ii) that topoisomerase IIbeta does not adopt these functions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9837951     DOI: 10.1074/jbc.273.50.33660

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

Review 1.  Topoisomerase II: untangling its contribution at the centromere.

Authors:  Andrew C G Porter; Christine J Farr
Journal:  Chromosome Res       Date:  2004       Impact factor: 5.239

2.  The geometry of DNA supercoils modulates topoisomerase-mediated DNA cleavage and enzyme response to anticancer drugs.

Authors:  A Kathleen McClendon; Neil Osheroff
Journal:  Biochemistry       Date:  2006-03-07       Impact factor: 3.162

3.  Depletion of topoisomerase IIalpha leads to shortening of the metaphase interkinetochore distance and abnormal persistence of PICH-coated anaphase threads.

Authors:  Jennifer M Spence; Hui Hui Phua; Walter Mills; Adam J Carpenter; Andrew C G Porter; Christine J Farr
Journal:  J Cell Sci       Date:  2007-10-23       Impact factor: 5.285

4.  Target genes of Topoisomerase IIβ regulate neuronal survival and are defined by their chromatin state.

Authors:  Vijay K Tiwari; Lukas Burger; Vassiliki Nikoletopoulou; Ruben Deogracias; Sudhir Thakurela; Christiane Wirbelauer; Johannes Kaut; Remi Terranova; Leslie Hoerner; Christian Mielke; Fritz Boege; Rabih Murr; Antoine H F M Peters; Yves-Alain Barde; Dirk Schübeler
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-02       Impact factor: 11.205

5.  The structure of DNA-bound human topoisomerase II alpha: conformational mechanisms for coordinating inter-subunit interactions with DNA cleavage.

Authors:  Timothy J Wendorff; Bryan H Schmidt; Pauline Heslop; Caroline A Austin; James M Berger
Journal:  J Mol Biol       Date:  2012-07-25       Impact factor: 5.469

6.  Bimodal recognition of DNA geometry by human topoisomerase II alpha: preferential relaxation of positively supercoiled DNA requires elements in the C-terminal domain.

Authors:  A Kathleen McClendon; Amanda C Gentry; Jennifer S Dickey; Marie Brinch; Simon Bendsen; Anni H Andersen; Neil Osheroff
Journal:  Biochemistry       Date:  2008-12-16       Impact factor: 3.162

7.  Topoisomerase IIalpha binding domains of adenomatous polyposis coli influence cell cycle progression and aneuploidy.

Authors:  Yang Wang; Robert J Coffey; Neil Osheroff; Kristi L Neufeld
Journal:  PLoS One       Date:  2010-04-02       Impact factor: 3.240

8.  (-)-Epigallocatechin gallate, a major constituent of green tea, poisons human type II topoisomerases.

Authors:  Omari J Bandele; Neil Osheroff
Journal:  Chem Res Toxicol       Date:  2008-02-23       Impact factor: 3.739

9.  Substituents on etoposide that interact with human topoisomerase IIalpha in the binary enzyme-drug complex: contributions to etoposide binding and activity.

Authors:  Ryan P Bender; Michael J Jablonksy; Mohammad Shadid; Ian Romaine; Norma Dunlap; Clemens Anklin; David E Graves; Neil Osheroff
Journal:  Biochemistry       Date:  2008-03-21       Impact factor: 3.162

10.  Phase I trial of vorinostat and doxorubicin in solid tumours: histone deacetylase 2 expression as a predictive marker.

Authors:  P N Munster; D Marchion; S Thomas; M Egorin; S Minton; G Springett; J-H Lee; G Simon; A Chiappori; D Sullivan; A Daud
Journal:  Br J Cancer       Date:  2009-09-08       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.